CytoMed Therapeutics Limited (NASDAQ: GDTC) Stock Information | RedChip
Image

ASK REDCHAT ANYTHING ABOUT CYTOMED THERAPEUTICS LIMITED

CytoMed Therapeutics Limited (NASDAQ: GDTC)
Listen to this Section


$1.00
+0.0110 ( +1.11% ) 0.1K

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The development of its novel technologies has been inspired by the clinical success of existing CAR-T cells in treating hematological malignancies as well as the current clinical limitations and commercial challenges in extrapolating the CAR-T principle into the treatment of solid tumors. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Market Data


Open $1.00
Previous Close $0.99
Volume 0.1K
Market Cap $11.71M
Day Range $0.99 - $1.09
52 Week Range $0.68 - $3.68
Shares Outstanding 11.83M
Change % +1.11%
Net Change ▲ 0.0110
Insider Ownership N/A
Exchange NASDAQ
SectorHealthcare
IndustryBiotechnology: Pharmaceutical Preparations
IPO Year2023
CountrySingapore
UnderwriterThe Benchmark Company, Axiom Capital Management, more

Insider Ownership Transactions

Total Amount Purchased: 0.00

Date Type Amount Purchased Purchaser
No records found.

SEC Filings


Form Type Description Pages Date
6-k Form 6-K 3 Nov 06, 2025
6-k Form 6-K 3 Oct 22, 2025
6-k Form 6-K 3 Oct 14, 2025
6-k Form 6-K 3 Oct 02, 2025
6-k Form 6-K 3 Sep 30, 2025
6-k Form 6-K 3 Aug 28, 2025
6-k Form 6-K 5 Aug 19, 2025
6-k Form 6-K 3 Jul 21, 2025
6-k Form 6-K 1 Jul 03, 2025
6-k Form 6-K 1 Jul 03, 2025

Latest News